Adenovirus-mediated interferon-γ transfer inhibits growth of transplanted HTLV-1 tax tumors in mice

Human Gene Therapy

Volumn 7, Issue 4, 1996, Pages 471-477

  Xu, Xiao ^a   Dai, Yifan ^b   Heidenreich, Olaf ^a   Nerenberg, Michael I ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA1;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; EXPERIMENTAL LEUKEMIA; GENE TRANSFER; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRUS CELL TRANSFORMATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; MUS MUSCULUS;

EID: 0029914289     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.4-471     Document Type: Article

References (26)

1. BIELEFELDT-OHMANN, H., FITZZPATRICK, D.R., MARZO, A.L., JARNICKI, A.G., MUSK, A.W., and ROBINSON, B.W.S. (1995). Potential for interferon-α-based therapy in mesothelioma: assessment in a murine model. J. Interferon & Cytokine Res. 15, 213-223.
2. BOST, K.L., BIELIGK, S.C., and JEFFE, B.M. (1995). Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. Tumor-derived IL-10 as a possible mechanism for modulating the anti-tumor response. J. Immunol. 154, 718-729.
3. CHEN, S.H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L. (1994). Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057.
4. DAI, Y.F., SCHWARZ, E.M., GU, D., ZHANG, W.W., SARVETNICK, N., and VERMA, I. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
5. GANSBACHER, B., BANNERJI, R., DANIELES, B., ZIER, K., CRONIN, K., and GILBOA, E. (1990). Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res. 50, 7820-7825.
6. GRAHAM, F.L., and PREVEC, L. (1992). Adenovirus-based expression vectors and recombinant vaccines. Biotechnology 20, 363-390.
7. GU, D., WOGENSEN, L., CALCUTT, N.A., XIA, C., ZHU, S., MERLIE, J.P., FOX, H.S., LINDSTROM, J., POWELL, H.C., and SARVETNICK, N. (1995). Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. J. Exp. Med. 181, 547-557.
8. GURUJEVALAKSHMI, G., and GIRI, S.N. (1994). Interferon gama downregulates procollagen a2(I) and transforming growth factor-β gene expression in bleomycin induced lung fibrosis in mice. FASEB J. (abstracts part II) 8, A690.
9. HOLLSBERG, P., AUSUBEL, L.J., and HAFLER, D.A. (1994). Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression. J. Immunol. 153, 566-573.
10. KITAJIMA, I., SHINOHARA, T., BILOKOVICS, J., BROWN, D.A., XU, X., and NERENBERG, M.I. (1992a). Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-κB. Science 258, 1792-1795.
11. KITAJIMA, I., SHINOHARA, T., MINOR, T., BIBBS, L., BILAKOVICS, J., and NERENBERG, M.I. (1992b). Human T-cell leukemia virus type I tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. J. Biol. Chem. 267, 25881-25888.
12. MEYERS, C.M., and KELLY, C.J. (1994). Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor. J. Clin. Invest. 94, 2093-2104.
13. MILLER, A.R., McBRIDE, W.H., HUNT, K., and ECONOMOU, J.S. (1994). Cytokine-mediated gene therapy for cancer. [Review] Ann. Surg. Oncol. 1, 436-450.
14. NERENBERG, M.I., HINRICHS, H., REYNOLDS, R.K., KHOURY, G., and JAY, G. (1987). The tat gene of human T-cell lymphotropic virus type-I induces mesenchymal tumors in transgenic mice. Science 237, 1324-1329.
15. O'MALLEY, B.W., JR., CHEN, S.H., SCHWARTZ, M.R., and WOO, S.L. (1995). Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 55, 1080-1085.
16. PANEK, R.B., LEE, Y.J., and BENVENISTE, E.N. (1995). TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression. J. Immunol. 154, 610-619.
17. PLAUTZ, G.E., NABEL, E.G., FOX, B., YANG, Z.Y., JAFFE, M., GORDON, D., CHANG, A., and NABEL, G.J. (1994). Direct gene transfer for the understanding and treatment of human disease. Ann. N.Y. Acad. Sci. 716, 144-153.
18. ROSENTHAL, F.M., ZIER, K.S., and GANSBACHER, B. (1994). Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicity. Curr. Opin. Oncol. 6, 611-615.
19. SAMUEL, S.K., HURTA, R.A., KONDAIAH, P., KHALIL, N., TURLEY, E.A., WRIGHT, J.A., and GREENBERG, A.H. (1992). Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225). EMBO J. 11, 1599-1605.
20. STOPPACCIARO, A., MELANI, C., PARENZA, M., MASTRACCHIO, A., BASSI, C., BARONI, C., PARMIANI, G., and COLOMBO, M.P. (1993). Regression of an established tumor genetically modified to release G-CSF requires granulocyte-T cell cooperation and T cell-produced IFN-γ. J. Exp. Med. 178, 151-161.
21. TENDLER, C.L., BURTON, J.D., JAFFE, J., DANELPOUR, D., CHARLEY, M., McCOY, J.P., PITTELKOW, M.R., and WALDMANN, T. (1994). Abnormal cytokine expression in Sezary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies. Cancer Res. 54, 4430-4435.
22. VIEWEG, J., and GILBOA, E. (1994). Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment. [Review] Cancer Invest. 13, 193-201.
23. WU, J.C., MERLINO, G., CVEKLOVA, K., MOSINGER, B., JR., and FAUSTO, N. (1994). Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Cancer Res. 54, 5964-5973.
24. XIE, J., and GALLAGHER, G. (1994). The ability of transforming growth factor-beta 1 to preferentially inhibit the induction of cytotoxicity in human T cells is determined by the nature of the activating signals. Anticancer Res. 14, 1595-1598.
25. YAMAMOTO, H., HIRAYAMA, M., GENYEA, C., and KAPLAN, J. (1994). TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes. J. Immunol. 152, 3842-3847.
26. ZHANG, X., WANG, T., BATIST, G., and TSAO, M.S. (1994). Transforming growth factor beta 1 promotes spontaneous transformation of cultured rat liver epithelial cells. Cancer Res. 54, 6122-6128.